<?xml version="1.0" encoding="UTF-8"?>
<STUDY_SET xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <STUDY center_name="BioProject" alias="PRJNA382611" accession="SRP105485">
    <IDENTIFIERS>
      <PRIMARY_ID>SRP105485</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioProject" label="primary">PRJNA382611</EXTERNAL_ID>
    </IDENTIFIERS>
    <DESCRIPTOR>
      <STUDY_TITLE>Specific integrin functions regulating the interplay between cancer cells and their microenvironment</STUDY_TITLE>
      <STUDY_TYPE existing_study_type="Whole Genome Sequencing"/>
      <STUDY_ABSTRACT>In many cancer types, integrin-mediated signaling regulates proliferation, survival, and invasion of tumorigenic cells1–3. However, it is still unclear how integrins crosstalk with oncogenes to regulate tumorigenesis and metastasis. Here, we show that oncogenic K-RasV12 upregulates a6-integrin expression in Madin-Darby canine kidney (MDCK) cells via activation of the mitogen-activated protein kinase (MAPK) / extracellular signal-regulated kinase (ERK) / Fos-related antigen 1 (FOSL1)-signaling cascade. Activated a6-integrins promoted anoikis resistance and led to perturbed growth and polarity of MDCK cysts. Transcriptomic analysis of K-RasV12-transformed MDCK cells also revealed robust downregulation of aV-class integrins. Re-expression of aV-integrin in K-RasV12-transformed MDCK cells synergistically upregulated the expression of Zinc finger E-box-binding homeobox 1 (ZEB1) and Twist-related protein 1 (TWIST1) and triggered epithelial-mesenchymal transition (EMT) leading to induced cell motility and invasion. Taken together, these results delineate the signaling cascades connecting oncogenic K-RasV12with a6- and aV-integrin functions to modulate cancer cell survival and tumorigenesis and reveal new possible strategies to target highly oncogenic K-RasV12-mutants.</STUDY_ABSTRACT>
      <CENTER_PROJECT_NAME>Canis lupus familiaris</CENTER_PROJECT_NAME>
    </DESCRIPTOR>
  </STUDY>
</STUDY_SET>
